Empire Financial Management Company’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Hold |
23,500
| – | – | 0.13% | 151 |
|
|
2025
Q1 | $423K | Buy |
23,500
+11,500
| +96% | +$207K | 0.13% | 149 |
|
|
2024
Q4 | $202K | Sell |
12,000
-2,250
| -16% | -$37.8K | 0.06% | 195 |
|
|
2024
Q3 | $231K | Buy |
+14,250
| New | +$231K | 0.07% | 188 |
|
|
2024
Q2 | – | Sell |
-30,450
| Closed | -$451K | – | 215 |
|
|
2024
Q1 | $451K | Buy |
30,450
+11,150
| +58% | +$165K | 0.15% | 147 |
|
|
2023
Q4 | $280K | Buy |
+19,300
| New | +$280K | 0.11% | 169 |
|